Ovarian Serous Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Serous Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with bevacizumab, with or without the anti-CD40 agonist CDX-1140, for recur…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study [Phase 2]
Phase 2 single-arm trial evaluating whether hyperthermic intraperitoneal chemotherapy (HIPEC) can enhance the efficacy of immune checkpoint …
-
CLINICAL_TRIALS research · 2015-04-30Clinical Trial Update: Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
A completed clinical trial update on developing immunological assays to evaluate tumor antigen-specific immunity. The study includes ovarian…